Pivotal Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported a loss of CAD 2,172,778, or CAD 0.02 per common share. In last year's second quarter, the loss was CAD 721,517 or CAD 0.01 per common share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +179,900.00% | -.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 172K | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2014